analogues was carried out. The new compounds demonstrated good cytotoxicity against
chronic myeloid leukemia (KBM5) and colon cancer (HCT116) cell lines. Further, these
compounds were found to have better potential to inhibit TNF‐α‐induced NF‐κB activation in
comparison to curcumin, which show their potential to act as anti‐inflammatory agents.
Some compounds were found to show higher cytotoxicity against cancer cell lines in …